1. Aziyo Biologics, a regenerative medicine company, voluntarily recalled a lot of its FiberCel product after several patients who received it tested positive for tuberculosis, according to the FDA.
2. DiFusion Technologies added Todd Potokar to its board of directors and named Rich Grant as chair of the board.
3. The FDA has provided clearance for Medtronic’s Vanta, a recharge free implantable neurostimulator.
4. SeaSpine’s WaveForm L 3D-printed interbody system was released in a limited commercial launch.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
